EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Groove Botanicals, Inc (GRVE) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of Groove Botanicals, Inc $0.00, price $0.00, upside -0.9%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Energy · US · ISIN US3988451072

GB Groove Botanicals, Inc logo Thin data Sep 27, 2026

Groove Botanicals, Inc

GRVE · US

NeutralThe stock looks roughly fairly valued with average quality.

·Fair value $0.0045 · Fairly valued (−0.9%)
!Quality 51/100
!Weak Growth (revenue 5y −53.3 %/yr)
!Negative equity (buybacks among others) · negative free cash flow
✓Ranks above peers (3/5)
!Narrow moat 6/100
!Evidence only low, so the estimate is less certain
Watch Groove Botanicals, Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.2900 $0.0012 Fair Value $0.0045 Jun 2015 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range $0.0012 – $0.2900 · fair‑value band $0.0044 – $0.0046 · the $0.0045 price screens above the $0.0045 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.

Follow Groove Botanicals in your weekly email

Every Wednesday you see whether Groove Botanicals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Groove Botanicals, Inc., focuses on identifying and evaluating potential licensing, development, or commercialization opportunities involving early-stage technologies and applied intellectual property that originate from universities and research institutions in Norway. The company was formerly known as Avalon Oil & Gas, Inc.

Show more

Groove Botanicals, Inc., focuses on identifying and evaluating potential licensing, development, or commercialization opportunities involving early-stage technologies and applied intellectual property that originate from universities and research institutions in Norway. The company was formerly known as Avalon Oil & Gas, Inc. and changed its name to Groove Botanicals, Inc. in May 2018. Groove Botanicals, Inc. is headquartered in Minneapolis, Minnesota.

Stock analysis

Groove Botanicals, Inc (GRVE) currently trades at $0.0045, while our model-based Fair Value estimate is $0.0045, so the stock looks roughly fairly valued today (gap 0.9%).

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the evidence level at low.

Scenario range: $0.0044 (bear) to $0.0046 (bull), the price of $0.0045 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Energy sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Groove Botanicals, Inc reported revenue of $0 in FY2026 versus $8.1K in FY2022. Reported net income was −$140K in FY2026.

Key figures

Market cap $268K · P/S ratio 30.4 · EPS (TTM) $−0.0100 · Return on assets (EBIT) −4,562% · Revenue (TTM) $8.1K · Revenue growth (YoY) +46.1% · Free cash flow −$91.7K · Net cash $1.5K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 18 out of 100 (low confidence).

What moves the price

The share trades about 81% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Energy peers we cover trades at 10% fair-value upside, at −1%, GRVE screens richer than that median.

Fair Value models

Bear $0.0044 Fair Value $0.0045 Bull $0.0046
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Gordon GGM $0.0300 $0.0600 $0.1000 64
DDM Multi-Stage $0.0300 $0.0600 $0.0700 64
All 2 models by family
Dividend Discount
Gordon GGM $0.0300 $0.0600 $0.1000 64
DDM Multi-Stage $0.0300 $0.0600 $0.0700 64

Open the full fair value analysis →

Notify me when GRVE reaches fair value

Put GRVE on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 51/100

Of which business quality 50 · Market factors (momentum, volatility) 28

Profitability 16
Margins and returns on capital today
Quality Growth 75
Are margins and returns improving?
Cashflow 55
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 25
Price trend over the last 3–12 months (market factor)
52W Momentum 10
Distance to the 52-week high (market factor)
Net Issuance 56
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−85.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−38.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−53.3%
Revenue growth 30 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−16.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−5,233.5% (2018) → −14,873.7% (2023)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

Watch GRVE, get fair value alerts →

Compare Groove Botanicals, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas E&P · 264 stocks

Beats the industry median on 3/5 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 50 · Above median
Fair Value upside −0.9% · Above median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Operating margin (TTM) 0.0% · Below median
Growth and dividend
Revenue growth 46.1% · Above median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Oil & Gas E&P median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 33.33× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)32 · sector 31
FUTURE (revenue growth)100 · sector 80
PAST (return on equity)0 · sector 19
HEALTH (low debt)0 · sector 86
DIVIDEND (yield)0 · sector 72

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

Similar stocks

10 more Oil & Gas E&P stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
ConocoPhillips explores for, COP $127.06 $91.42 −28%
CNOOC Limited 0883 HK$23.40 HK$39.91 +71%
Canadian Natural Resources Limited CNQ $47.55 $52.31 +10%
EOG Resources, Inc EOG $137.76 $165.02 +20%
Occidental Petroleum Corporation OXY $56.86 $33.18 −42%
Devon Energy Corporation DVN $46.73 $51.40 +10%
Diamondback Energy, Inc FANG $185.23 $243.76 +32%
Woodside Energy Group WDS A$31.48 A$23.87 −24%
EQT Corporation EQT $50.81 $55.89 +10%
Texas Pacific Land Corporation TPL $341.07 $317.06 −7%

Explore undervalued stocks

More undervalued Energy stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Groove Botanicals, Inc · Fair Value
$0.0045 −1%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Groove Botanicals, Inc Fair Value". https://www.fairvalue-calculator.com/stock/GRVE

Frequently asked questions

Is Groove Botanicals, Inc (GRVE) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0045 versus a price of $0.0045, about −1% upside (fairly valued).
What is the fair value of GRVE?
Our model-based fair value for Groove Botanicals, Inc is $0.0045 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0045.
What is the quality score of GRVE?
Groove Botanicals, Inc has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Groove Botanicals, Inc (GRVE)?
Our model-based price target is the fair value of $0.0045 (as of Sep 27, 2026) from 2 valuation models. Cautious scenario $0.0044, optimistic scenario $0.0046. It is a calculation from audited fundamentals, not an analyst target.
What is the Groove Botanicals, Inc stock forecast for 2026?
Our models put fair value at $0.0045, about −1% upside versus a price of $0.0045 (fairly valued). Cautious scenario $0.0044, optimistic scenario $0.0046. The calculation is refreshed regularly with new filings.
What is the revenue of Groove Botanicals, Inc (GRVE)?
Groove Botanicals, Inc reported trailing-twelve-month revenue of about $8.1K (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Groove Botanicals, Inc (GRVE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Groove Botanicals, Inc it is $0.0045 per share (as of Sep 27, 2026), against a price of $0.0045. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Groove Botanicals, Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, GRVE trades above its calculated fair value: price $0.0045, fair value $0.0045, a gap of about −1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GRVE?
No. The price is what the market pays today ($0.0045); the fair value is what the company's own numbers justify ($0.0045). For Groove Botanicals, Inc the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Groove Botanicals, Inc worth?
The market values Groove Botanicals, Inc at about $268K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0045; our models calculate a fair value of $0.0045 per share.
What do the bullish and bearish scenarios say about GRVE?
Our models span a range for Groove Botanicals, Inc: cautious scenario $0.0044, base $0.0045, optimistic $0.0046 per share (as of Sep 27, 2026, price $0.0045). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Groove Botanicals, Inc (GRVE)?
Balance-sheet figures for Groove Botanicals, Inc (as of Sep 27, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is GRVE from its 52-week high?
Groove Botanicals, Inc trades at $0.0045, about 81% below its 52-week high of $0.0232 and 13% above the low of $0.0040 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0045 is for.
Which stocks are comparable to Groove Botanicals, Inc?
From the same area (Energy) we also value ConocoPhillips explores for,, CNOOC Limited, Canadian Natural Resources Limited, EOG Resources, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Groove Botanicals, Inc stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0045, calculated fair value $0.0045 (−1%), Quality Score 51/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GRVE calculated?
We run Groove Botanicals, Inc through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0045, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Groove Botanicals, Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Groove Botanicals, Inc (GRVE)?
The closing price on Oct 1, 2026 was $0.0045. Our model-based fair value is $0.0045, about −1% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Groove Botanicals, Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0044 to $0.0046), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Groove Botanicals, Inc

How large is the market capitalisation of Groove Botanicals, Inc (GRVE)?
The market capitalisation of Groove Botanicals, Inc is $268K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Groove Botanicals, Inc (GRVE)?
The price-to-sales ratio of Groove Botanicals, Inc is 30.4 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Groove Botanicals, Inc (GRVE)?
Earnings per share at Groove Botanicals, Inc are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of Groove Botanicals, Inc (GRVE)?
On an EBIT basis the return on assets of Groove Botanicals, Inc is −4,562% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How fast is revenue growing at Groove Botanicals, Inc (GRVE)?
Revenue at Groove Botanicals, Inc is growing +46.1% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Groove Botanicals, Inc (GRVE) generate?
The free cash flow of Groove Botanicals, Inc is −$91.7K (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Groove Botanicals, Inc (GRVE) hold?
Groove Botanicals, Inc holds more cash than debt, $1.5K net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Groove Botanicals, Inc in the live analysis

One click puts Groove Botanicals, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.